再生障碍性贫血的临床管理。
Clinical management of aplastic anemia.
机构信息
Division of Medical Oncology, Department of Medicine, The Johns Hopkins School of Medicine, 720 Rutland Avenue, Baltimore, MD 21205, USA.
出版信息
Expert Rev Hematol. 2011 Apr;4(2):221-30. doi: 10.1586/ehm.11.11.
Abstract
Acquired aplastic anemia is a potentially fatal bone marrow failure disorder that is characterized by pancytopenia and a hypocellular bone marrow. Hematopoietic stem-cell transplantation or bone marrow transplantation (BMT) is the treatment of choice for young patients who have a matched sibling donor. Immunosuppression with either anti-thymocyte globulin and cyclosporine or high-dose cyclophosphamide is an effective therapy for patients who are not suitable BMT candidates owing to age or lack of a suitable donor. Results of BMT from unrelated and mismatched donors are improving, but presently this treatment option is best reserved for those patients who do not respond, relapse or develop secondary clonal disorders following immunosuppressive therapy. Efforts are currently underway to both improve immunosuppressive regimens and to expand the application of BMT.
摘要
获得性再生障碍性贫血是一种潜在致命的骨髓衰竭疾病，其特征是全血细胞减少和骨髓细胞减少。造血干细胞移植或骨髓移植（BMT）是有匹配的同胞供体的年轻患者的首选治疗方法。对于由于年龄或缺乏合适供体而不适合 BMT 候选者的患者，用抗胸腺细胞球蛋白和环孢菌素或大剂量环磷酰胺进行免疫抑制是一种有效的治疗方法。无关和不匹配供体的 BMT 结果正在改善，但目前这种治疗选择最好保留给那些在免疫抑制治疗后无反应、复发或发生继发性克隆疾病的患者。目前正在努力改善免疫抑制方案并扩大 BMT 的应用。
相似文献
1
Clinical management of aplastic anemia.再生障碍性贫血的临床管理。
Expert Rev Hematol. 2011 Apr;4(2):221-30. doi: 10.1586/ehm.11.11.
2
First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.与一线使用环孢素和/或抗胸腺细胞或抗淋巴细胞球蛋白治疗获得性重型再生障碍性贫血相比，HLA匹配的同胞供者进行一线异基因造血干细胞移植的情况。
Cochrane Database Syst Rev. 2013 Jul 23;2013(7):CD006407. doi: 10.1002/14651858.CD006407.pub2.
3
Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.环磷酰胺及体内抗CD52单克隆抗体对急性和慢性移植物抗宿主病的有利影响，用于人类白细胞抗原（HLA）匹配的同胞供者骨髓移植治疗获得性再生障碍性贫血。
Biol Blood Marrow Transplant. 2004 Dec;10(12):867-76. doi: 10.1016/j.bbmt.2004.09.001.
4
Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study.接受非亲缘骨髓移植的重型再生障碍性贫血患者的环磷酰胺预处理：一项1-2期剂量递减研究
Lancet Haematol. 2015 Sep;2(9):e367-75. doi: 10.1016/S2352-3026(15)00147-7. Epub 2015 Sep 2.
5
Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.重型再生障碍性贫血骨髓移植时的预处理方案选择。
Blood Adv. 2019 Oct 22;3(20):3123-3131. doi: 10.1182/bloodadvances.2019000722.
6
Alternative Donor Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Refractory Severe Aplastic Anemia.采用大剂量移植后环磷酰胺的替代供体移植治疗难治性重型再生障碍性贫血
Biol Blood Marrow Transplant. 2017 Mar;23(3):498-504. doi: 10.1016/j.bbmt.2016.12.628. Epub 2016 Dec 21.
7
Haploidentical Donor Bone Marrow Transplantation for Severe Aplastic Anemia.单倍体相合供者骨髓移植治疗重型再生障碍性贫血
Hematol Oncol Clin North Am. 2018 Aug;32(4):629-642. doi: 10.1016/j.hoc.2018.04.001. Epub 2018 May 28.
8
Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.低剂量抗胸腺细胞球蛋白在成人获得性重型再生障碍性贫血无关供者干细胞移植中的有益作用：降低移植物抗宿主病并提高无移植物抗宿主病、无失败生存率
Biol Blood Marrow Transplant. 2017 Sep;23(9):1498-1508. doi: 10.1016/j.bbmt.2017.05.026. Epub 2017 May 26.
9
Allogeneic hematopoietic stem cell transplantation in aplastic anemia: current indications and transplant strategies.再生障碍性贫血的异基因造血干细胞移植：当前的适应证及移植策略
Blood Rev. 2021 May;47:100772. doi: 10.1016/j.blre.2020.100772. Epub 2020 Oct 31.
10
Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation.青少年再生障碍性贫血的结局：欧洲血液与骨髓移植组严重再生障碍性贫血工作组的一项调查
Haematologica. 2014 Oct;99(10):1574-81. doi: 10.3324/haematol.2014.106096. Epub 2014 Aug 1.
引用本文的文献
1
Modified Delphi panel consensus recommendations for management of severe aplastic anemia.改良 Delphi 法-panel 共识推荐的再生障碍性贫血严重程度的管理建议。
Blood Adv. 2024 Aug 13;8(15):3946-3960. doi: 10.1182/bloodadvances.2023011642.
2
Effect of Stanozolol combined with Cyclosporine A on aplastic anemia.司坦唑醇联合环孢素A对再生障碍性贫血的影响
Am J Transl Res. 2023 Nov 15;15(11):6660-6666. eCollection 2023.
3
Very Severe Aplastic Anemia in a 26-Year-Old Male: Implications for Prognosis and Treatment Options.一名26岁男性的极重型再生障碍性贫血：对预后和治疗选择的影响
Cureus. 2023 Sep 22;15(9):e45750. doi: 10.7759/cureus.45750. eCollection 2023 Sep.
4
Alternative treatment modality for severe aplastic anemia in a resource-limited setting: a single-institution prospective cohort study from Upper Egypt.资源有限环境下严重再生障碍性贫血的替代治疗方式：来自埃及上埃及的单机构前瞻性队列研究。
Ann Hematol. 2023 Nov;102(11):2997-3006. doi: 10.1007/s00277-023-05440-x. Epub 2023 Sep 13.
5
Efficacy of Oxymetholone in Severe and Nonsevere Acquired Aplastic Anemia: A Propensity Score Matching Analysis.氧甲氢龙治疗重度和非重度获得性再生障碍性贫血的疗效：一项倾向评分匹配分析
J Blood Med. 2022 Dec 7;13:753-761. doi: 10.2147/JBM.S383148. eCollection 2022.
6
Panaxdiol saponins component promotes hematopoiesis by regulating GATA transcription factors of intracellular signaling pathway in mouse bone marrow.人参二醇皂苷成分通过调节小鼠骨髓细胞内信号通路的GATA转录因子促进造血。
Ann Transl Med. 2022 Jan;10(2):38. doi: 10.21037/atm-21-4800.
7
Hematopoietic Stem-Cell Transplantation versus Immunosuppressive Therapy in Patients with Adult Acquired Severe Aplastic Anemia: A Cost-Effectiveness Analysis.成人获得性重型再生障碍性贫血患者造血干细胞移植与免疫抑制治疗的成本效益分析
Int J Gen Med. 2021 Jul 15;14:3529-3537. doi: 10.2147/IJGM.S310844. eCollection 2021.
8
Association of Interleukin-1β-31C/T, -511T/C and -3954C/T Single Nucleotide Polymorphism and Their Blood Plasma Level in Acquired Aplastic Anemia.白细胞介素-1β -31C/T、-511T/C和-3954C/T单核苷酸多态性与获得性再生障碍性贫血患者血浆水平的相关性
Indian J Hematol Blood Transfus. 2021 Apr;37(2):210-219. doi: 10.1007/s12288-020-01281-0. Epub 2020 Apr 26.
9
Combination of umbilical cord mesenchymal stem cells and standard immunosuppressive regimen for pediatric patients with severe aplastic anemia.脐带间充质干细胞联合标准免疫抑制方案治疗儿童重型再生障碍性贫血。
BMC Pediatr. 2021 Feb 27;21(1):102. doi: 10.1186/s12887-021-02562-x.
10
Prognostic value of TNF-a-308 and IFN-g-874 single nucleotide polymorphisms and their plasma levels in patients with aplastic anemia.肿瘤坏死因子-α-308和干扰素-γ-874单核苷酸多态性及其血浆水平在再生障碍性贫血患者中的预后价值。
Blood Res. 2020 Dec 31;55(4):193-199. doi: 10.5045/br.2020.2020009.
本文引用的文献
1
Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia.外周血白细胞端粒长度与重型再生障碍性贫血造血复发、恶性转化和生存的关系。
JAMA. 2010 Sep 22;304(12):1358-64. doi: 10.1001/jama.2010.1376.
2
Post-transplantation cyclophosphamide for GVHD prophylaxis in severe aplastic anemia.移植后环磷酰胺用于重型再生障碍性贫血移植物抗宿主病的预防
Bone Marrow Transplant. 2011 Jul;46(7):1012-3. doi: 10.1038/bmt.2010.213. Epub 2010 Sep 13.
3
Fludarabine-based conditioning chemotherapy for allogeneic hematopoietic stem cell transplantation in acquired severe aplastic anemia.氟达拉滨为基础的预处理化疗用于获得性重型再生障碍性贫血的异基因造血干细胞移植。
Biol Blood Marrow Transplant. 2011 May;17(5):717-22. doi: 10.1016/j.bbmt.2010.08.013. Epub 2010 Aug 22.
4
Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine.阵发性睡眠性血红蛋白尿症克隆在接受马抗胸腺细胞球蛋白加环孢素治疗的重型再生障碍性贫血患者中出现。
Haematologica. 2010 Jul;95(7):1075-80. doi: 10.3324/haematol.2009.017889.
5
Risks and outcome of fungal infection in neutropenic children with hematologic diseases.血液系统疾病中性粒细胞减少儿童真菌感染的风险与转归
Turk J Pediatr. 2010 Mar-Apr;52(2):121-5.
6
The characteristics and clinical outcome of adult patients with aplastic anemia and abnormal cytogenetics at diagnosis.再生障碍性贫血患者诊断时细胞遗传学异常的特征和临床结局。
Genes Chromosomes Cancer. 2010 Sep;49(9):844-50. doi: 10.1002/gcc.20793.
7
Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry.流式细胞术诊断和监测阵发性睡眠性血红蛋白尿症及相关疾病的指南。
Cytometry B Clin Cytom. 2010 Jul;78(4):211-30. doi: 10.1002/cyto.b.20525.
8
Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party.对于所有接受抗胸腺细胞球蛋白（ATG）免疫抑制治疗的再生障碍性贫血患者，是否应常规给予辐照血液制品？来自欧洲血液和骨髓移植学会重型再生障碍性贫血工作组的一项调查。
Br J Haematol. 2010 Aug;150(3):377-9. doi: 10.1111/j.1365-2141.2010.08200.x. Epub 2010 May 26.
9
Clinical course of non-severe aplastic anemia in adults.成人非重型再生障碍性贫血的临床病程。
Int J Hematol. 2010 Jun;91(5):770-5. doi: 10.1007/s12185-010-0601-1. Epub 2010 Jun 5.
10
Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party.氟达拉滨、环磷酰胺、抗胸腺细胞球蛋白联合或不联合低剂量全身照射，用于异基因供者移植治疗获得性重型再生障碍性贫血：来自 EBMT-SAA 工作组的回顾性研究。
Haematologica. 2010 Jun;95(6):976-82. doi: 10.3324/haematol.2009.018267. Epub 2010 May 21.
Zotero 插件